Theoretical concepts and the emerging role of taxanes in adjuvant therapy.

The proven benefits of adjuvant chemotherapy on disease-free and overall survival in breast cancer can be explained by concepts of cell kill. Interventions which result in greater log kill can be expected to produce improved clinical results. The application of log-kill concepts to human breast cancer growth, which appears to follow Gompertzian kinetics, suggests not only that the use of non-cross-resistant drugs is important, but that dose-dense schedules may have an advantage over conventional schedules of drug administration. Sequential therapy may allow dose-dense administration of cytotoxic agents and encourage the integration of new biological agents into combination regimens, particularly with the taxanes. Ongoing trials in these concepts are reviewed.
AuthorsL Norton
JournalThe oncologist (Oncologist) Vol. 6 Suppl 3 Pg. 30-5 ( 2001) ISSN: 1083-7159 [Print] United States
PMID11346683 (Publication Type: Journal Article, Review)
Chemical References
  • Bridged Compounds
  • Taxoids
  • taxane
  • Breast Neoplasms (drug therapy)
  • Bridged Compounds (therapeutic use)
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Taxoids
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: